These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18693124)

  • 21. Tumoral calcinosis regression after subtotal parathyroidectomy: a case presentation and review of the literature.
    Thakur A; Hines OJ; Thakur V; Gordon HE
    Surgery; 1999 Jul; 126(1):95-8. PubMed ID: 10418601
    [No Abstract]   [Full Text] [Related]  

  • 22. [Secondary hyperparathyroidism manifesting as cutaneous gangrene in a patient on hemodialysis (uremic gangrene syndrome)].
    Török L; Középessy L; Suhajda K
    Hautarzt; 1990 Dec; 41(12):689-91. PubMed ID: 2089028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Moldovan D; Racasan S; Kacso IM; Rusu C; Potra A; Bondor C; Patiu IM; Gherman-Căprioară M
    Int Urol Nephrol; 2015 Nov; 47(11):1871-7. PubMed ID: 26377492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumoral calcinosis due to severe hyperphosphatemia and secondary hyperparathyroidism without vascular calcification in a hemodialysis patient.
    Saito T; Mizobuchi M; Hamada T; Sugiyama M; Miyazawa N; Morikawa T; Matsumoto K; Yoshitake O; Aoki T; Murakami M; Honda H
    Clin Nephrol; 2021 Mar; 95(3):166-170. PubMed ID: 33433319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumoral calcinosis in hemodialysis patients. A review of three cases.
    Franco M; Van Elslande L; Passeron C; Verdier JF; Barrillon D; Cassuto-Viguier E; Pettelot G; Bracco J
    Rev Rhum Engl Ed; 1997 Jan; 64(1):59-62. PubMed ID: 9051862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical characteristics of 10 patients with uremic tumoral calcinosis].
    Xiong M; Wang J; Li XD; Yu YW; Zhang L
    Zhonghua Nei Ke Za Zhi; 2020 Nov; 59(11):860-865. PubMed ID: 33120489
    [No Abstract]   [Full Text] [Related]  

  • 27. A case study with delayed renal graft function as a consequence of severe secondary hyperparathyroidism.
    Backman U; Butler G; Fletchner P; McMullin J
    Artif Organs; 1995 Jan; 19(1):72-5. PubMed ID: 7741643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Posttransplant regression of uremic tumoral calcinosis].
    de Alarcón RM; Palomares M; Marfil A; Asensio C
    Nefrologia; 2007; 27(3):378-81. PubMed ID: 17725459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD.
    Bleyer AJ; Burkart J; Piazza M; Russell G; Rohr M; Carr JJ
    Am J Kidney Dis; 2005 Sep; 46(3):464-9. PubMed ID: 16129208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
    Iseki K
    Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Extensive calcification of the muscles caused by secondary hyperparathyroidism in a patient with terminal renal failure, treated by repeated hemodialysis and parathyroidectomy].
    Hanicki Z; Smoleński O; Sułowicz W; Kopeć J
    Przegl Lek; 1983; 40(7):593-7. PubMed ID: 6635256
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of Severe Tumoral Calcinosis with Teriparatide in a Dialysis Patient after Total Parathyroidectomy.
    Sin HK; Wong PN; Lo KY; Lo MW; Chan SF; Lo KC; Wong YY; Ho LY; Kwok WT; Chan KC; Wong AK; Mak SK
    Case Rep Nephrol; 2021; 2021():6695906. PubMed ID: 33505741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of subtotal parathyroidectomy in patients on haemodialysis].
    Vujić D; Majster Z; Lazić N; Radmirović A; Kekić Z
    Srp Arh Celok Lek; 1994; 122(1-2):34-7. PubMed ID: 17972801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy.
    Cofan F; García S; Combalia A; Campistol JM; Oppenheimer F; Ramón R
    J Rheumatol; 1999 Feb; 26(2):379-85. PubMed ID: 9972973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of complications related to secondary hyperparathyroidism in a peritoneal dialysis patient.
    Kleinpeter MA
    Adv Perit Dial; 2000; 16():286-90. PubMed ID: 11045312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is nephrogenic ascites related to secondary hyperparathyroidism?
    Nasr EM; Joubran NI
    Am J Kidney Dis; 2001 Feb; 37(2):E16. PubMed ID: 11157402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumoral calcinosis: Diffuse multifocal form in hemodialysis patients. Two case reports.
    Ibrahim Montasser D; Issouani J; Hassani M; Kabbaj D
    Orthop Traumatol Surg Res; 2017 Sep; 103(5):815-820. PubMed ID: 28576700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Uremic Tumoral Calcinosis in Maintenance Hemodialysis Patients.
    Ke G; Li S; Cui Y; Chen X; Che H; Dou C; Lian Z; Zhang L; Li Z; Ma J; Feng Z; Yang J; Hu Y; Wang Y; Zhang H; Huang H; Su H; Guo J; He C; Liang X; Shi W; Ge P; Liu S
    Blood Purif; 2020; 49(6):658-664. PubMed ID: 32289781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corneal and Conjunctival Calcification in a Dialysis Patient Reversed by Parathyroidectomy.
    Pessoa MBCN; Santo RM; De Deus AA; Duque EJ; Rochitte CE; Moyses RMA; Elias RM
    Blood Purif; 2021; 50(2):254-256. PubMed ID: 33302281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 23-year-old patient with secondary tumoral calcinosis: Regression after subtotal parathyroidectomy: A case report.
    Niemann KE; Kröpil F; Hoffmann MF; Coulibaly MO; Schildhauer TA
    Int J Surg Case Rep; 2016; 23():56-60. PubMed ID: 27088846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.